Biostat STR Generation 3
A single-use bioreactor system that dramatically enhances speed, quality, and productivity from process development to scale-up.
The "Biostat STR Series" is a single-use bioreactor system designed for rapid process development and seamless scale-up to commercial production. The newly launched third generation features a new automation platform, "BIOBRAIN," and the analytical tool "BioPAT(R)," enabling exceptional speed, quality, and productivity. Stable and predictable processes greatly contribute to providing safe and reliable biopharmaceuticals to patients worldwide, accelerating our customers' manufacturing operations and business.
basic information
Large-scale single-use bioreactor system ■ Equipped with the analysis tool "BioPAT(R)" and the automation platform "BIOBRAIN" ■ Compatible with volumes from 12.5 L to 2000 L ■ Enhanced bioreactor operation
Price range
Delivery Time
Applications/Examples of results
Cell culture / Process development and commercial production for pharmaceuticals.
Detailed information
Related Videos
catalog（13）
Download All Catalogs
News about this product（8）
-
[Sending recorded video] Microbial culture using a single-use culture device.
Participation in this webinar has ended. If you wish to view it, please contact us. We will send you the URL for the recorded video at a later date. As the number of pharmaceutical companies working on gene therapy and vaccines increases, the need for culture devices for microorganisms using single-use technology is becoming more and more critical. Sartorius has developed the Biostat STR MO to meet this demand. This webinar will introduce the features and application examples of Sartorius's first single-use culture device for microorganisms, the Biostat STR MO. [Seminar Overview] Date: May 18, 2023 (Thursday) from 3:00 PM (approximately 30 minutes) Webinar recorded broadcast [Japanese, free] We will send the recorded video and the download URL for related product materials to those who registered at a later date. *We apologize, but participation from other companies in the same industry and email addresses not affiliated with your organization is not permitted. Thank you for your understanding.
-
[Sending recorded video] Cutting-edge pDNA and AAV therapeutics: Comprehensive upstream process technology covering everything from process development to actual production.
Participation in this webinar has ended. If you wish to view it, please contact us. We will send you the URL for the recorded video at a later date. The development of therapeutics using viral vectors is showing strong activity, with over 30% market growth expected in the next decade. The targets for treatment are diverse, but identifying critical process parameters through process development has become an urgent issue. As the first of two webinars, we will introduce the Ambr series, a representative of process development systems in upstream processes, as well as single-use bag bioreactors up to 2000L for large-scale manufacturing, including examples of associated PAT products. *We sincerely apologize, but participation from email addresses other than those of your company or organization is not permitted. Thank you for your understanding.
-
"We will send you a recorded video" upgraded single-use bag bioreactor for process enhancement.
Participation in this webinar has ended. If you wish to view it, please contact us. We will send you the URL for the recorded video at a later date. Since 2020, Sartorius has been continuously working towards process enhancement, and in February, we introduced two bioreactors using single-use bags as the completed form of the enhanced upstream process. We will present the full details of the bioreactor system that meets the needs of commercial production and automation, along with case studies, in this webinar. Related site: https://srtrs.info/r/d7yvo
-
Sending recorded video: What are the equipment requirements needed for the process enhancement challenge?
Participation in this webinar has ended. If you wish to view it, please contact us, and we will send you the URL for the recorded video at a later date. Since last year, Sartorius has been presenting various proposals and suitable solutions for the challenges of "enhancing processes." In this first webinar of 2022, we will delve deeper than last year's trilogy and discuss several examples regarding cost and equipment considerations. The focus will particularly be on how to manage media that significantly impacts costs and how to design equipment. Please note that this webinar will be presented as the Japanese version of the overseas webinar "Overcoming Facility Constraints Posed by Process Intensification." ▪ Method of holding: Webinar recorded broadcast [Japanese, Free]
-
[Sending recorded video] 11/2 [Every Tuesday in Japan] Process Enhancement Series, all 3 sessions - Session 2: High-Throughput Bioreactor Supporting Process Enhancement Efforts
Participation in this webinar has ended. If you wish to view it, please contact us, and we will send you the URL for the recorded video at a later date. The success or failure of the cultivation process significantly contributes to subsequent productivity, quality, and yield, even within the overall enhanced process. Therefore, the role of process development and optimization for cultivation is positioned as extremely important, and it is necessary to implement these approaches in conjunction with production bioreactors. As the number of considerations increases, there is a demand for cost and labor reduction, and our Amber System is the solution to achieve this. Since 2020, our model capable of perfusion cultivation has received positive feedback, and in the second installment, we will thoroughly convey this feature and its advantages. [Learnable Elements] - Evolved approaches to process development - Advantages of parallel implementation in multi-channel setups [Method of Hosting] Webinar recorded broadcast [Japanese, Free] *Special novelty items will be sent from our company to those who participated in all sessions from the first to the third on the same day.
